Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
You are not activating adrenergic receptors throughout your body
This multi-receptor approach distinguishes it from existing licensed medicines such as semaglutide (Ozempic, Wegovy) or tirzepatide licensed in the UK as Mounjaro for type 2 diabetes and as Zepbound for obesity which act on fewer receptor pathways
Treat every efficacy statement here as studies suggest or in animal models, never as established human benefit
Each batch is analyzed to ensure consistent quality
A clean supply chain is the silent prerequisite to any of this becoming meaningful
US$ 28.98
US$ 25.71
US$ 24.57
